{"id":"W2960318035","doi":"10.1016/j.euo.2019.06.008","title":"Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis","year":2019,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Enzalutamide; Medicine; Abiraterone; Prostate cancer; Prostate-specific antigen; Oncology; Prostate; Internal medicine; Cancer; Urology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002413036,0.0003577542,0.0007619548,0.0003622281,0.0001903867,0.00004071156,0.0001029109,0.0001150739,0.0001711823],"category_scores_gemma":[0.00001508609,0.0002614281,0.00009980876,0.0002566671,0.0003528316,0.0001759011,0.0001065614,0.0001173481,0.00005410611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008753116,"about_ca_system_score_gemma":0.0002557517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001373772,"about_ca_topic_score_gemma":0.000468669,"domain_scores_codex":[0.997641,0.0003730503,0.0003786129,0.0009264718,0.0001445631,0.000536248],"domain_scores_gemma":[0.998656,0.0001633085,0.0001999408,0.0003463656,0.0003447506,0.0002896228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0413713,0.001275148,0.7153254,0.00003878099,0.00501957,0.0007164977,0.0123244,0.0001713875,0.09538753,0.000126998,0.00009419366,0.1281488],"study_design_scores_gemma":[0.0267921,0.05955995,0.6792968,0.00001336602,0.000930913,0.00007579268,0.0006323117,0.0002626215,0.004069477,0.00002470219,0.228002,0.0003400407],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863395,0.004423146,0.000006149766,0.003666244,0.0002797419,0.002842452,0.000611679,0.00006600504,0.001765067],"genre_scores_gemma":[0.9752952,0.01476606,0.000623064,0.0003866149,0.0001357282,0.0004043918,0.000869893,0.00006238576,0.007456688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2279078,"threshold_uncertainty_score":0.9999838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02138667967309145,"score_gpt":0.335426463842839,"score_spread":0.3140397841697475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}